A carregar...
Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells
Approximately 20% of breast cancers are HER2-positive. Trastuzumab has improved patient outcomes significantly for these cancers. However, acquired resistance remains a major hurdle in the clinical management of these patients. Therefore, identifying molecular changes that cause trastuzumab resistan...
Na minha lista:
| Publicado no: | PLoS One |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7289443/ https://ncbi.nlm.nih.gov/pubmed/32525891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0234146 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|